In vitro stem cell differentiation into cardiomyocytes

Ioannis Dimarakis , Natasa Levicar , Petros Nihoyannopoulos , Nagy A. Habib , Myrtle Y. Gordon
{"title":"In vitro stem cell differentiation into cardiomyocytes","authors":"Ioannis Dimarakis ,&nbsp;Natasa Levicar ,&nbsp;Petros Nihoyannopoulos ,&nbsp;Nagy A. Habib ,&nbsp;Myrtle Y. Gordon","doi":"10.1016/j.jccr.2006.06.001","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Recent developments in the field of regenerative stem cell therapy for </span>ischaemic heart disease<span> have lead to an explosion in the clinical trial realm. At present no consensus exists regarding, amongst others, the optimal cell type as well as the underlying mechanism of action for any clinical improvement observed. As de novo reconstitution of myocardial tissue from multipotent stem cells<span> is one of the working theories, the transdifferentiation potential of cellular populations under investigation into </span></span></span>cardiomyocyte lineage phenotypes must ideally be assessed in preclinical bench work. Culture medium composition and a variety of growth factors are crucial determinants in this process. We discuss all relevant data acquired from in vitro work.</p></div>","PeriodicalId":100759,"journal":{"name":"Journal of Cardiothoracic-Renal Research","volume":"1 2","pages":"Pages 107-114"},"PeriodicalIF":0.0000,"publicationDate":"2006-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jccr.2006.06.001","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiothoracic-Renal Research","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1574066806000385","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Recent developments in the field of regenerative stem cell therapy for ischaemic heart disease have lead to an explosion in the clinical trial realm. At present no consensus exists regarding, amongst others, the optimal cell type as well as the underlying mechanism of action for any clinical improvement observed. As de novo reconstitution of myocardial tissue from multipotent stem cells is one of the working theories, the transdifferentiation potential of cellular populations under investigation into cardiomyocyte lineage phenotypes must ideally be assessed in preclinical bench work. Culture medium composition and a variety of growth factors are crucial determinants in this process. We discuss all relevant data acquired from in vitro work.

体外干细胞分化为心肌细胞
再生干细胞治疗缺血性心脏病领域的最新进展导致了临床试验领域的爆炸式发展。目前,对于最佳细胞类型以及观察到的任何临床改善的潜在作用机制,还没有达成共识。由于从多能干细胞重新构建心肌组织是一种有效的理论,因此在对心肌细胞谱系表型进行研究的细胞群体的转分化潜力必须在临床前的台架工作中进行评估。培养基组成和各种生长因子是这一过程的关键决定因素。我们讨论了从体外工作中获得的所有相关数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信